Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, announced that the US Food and Drug Administration (FDA) approved the TECNIS ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the Tecnis Eyhance and Tecnis Eyhance toric II IOLs for the treatment of patients with cataract ...

Please provide your email address to receive an email when new articles are posted on . In a study, the Tecnis Eyhance toric II IOL had good rotational stability over 3 months, significant reduction ...

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...

SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.

“The Eyhance monofocal IOL was introduced into our practice as a next-generation IOL offering to slightly extend the range of vision for our patients undergoing cataract surgery. However, we observed ...